A carregar...
Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients
We evaluated the plasma and intracellular pharmacokinetics, clinical efficacy, and safety of once-daily low-dose boosted saquinavir (SQVr; 1,200 of saquinavir [SQV] with 100 mg of ritonavir) plus two nucleotide reverse transcriptase inhibitors in treatment-naive or limited protease inhibitor (PI)-ex...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Microbiology
2007
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1891384/ https://ncbi.nlm.nih.gov/pubmed/17371813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01136-06 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|